Back to Search
Start Over
Does new onset and pre-existing atrial fibrillation predict mortality in COVID-19 patients?
- Source :
- The Egyptian Heart Journal, Vol 74, Iss 1, Pp 1-8 (2022)
- Publication Year :
- 2022
- Publisher :
- SpringerOpen, 2022.
-
Abstract
- Abstract Background Coronavirus Disease-2019 (COVID-19), caused by Severe Acute Respiratory Syndrome-Coronavirus-2, still remains prevalent and severe. We aimed to evaluate the effects of pre-existing atrial fibrillation and new-onset atrial fibrillation (NOAF) on the clinical severity and mortality of COVID-19. Results Between April and December 2020, 5577 patients with positive PCR and/or COVID-19 compatible findings in computed tomography hospitalized were enrolled retrospectively. Total and in-hospital mortality, need for intensive care unit (ICU), need for mechanical ventilation, and recurrent hospitalization results of 286 patients with pre-existing AF before hospitalization and 82 patients with NOAF during hospitalization were evaluated. Preexisting AF was associated with a 2-fold increase in total and in-hospital mortality [OR (2.16 (1.62–2.89), 2.02 (1.48–2.76), P
Details
- Language :
- English
- ISSN :
- 2090911X and 84962984
- Volume :
- 74
- Issue :
- 1
- Database :
- Directory of Open Access Journals
- Journal :
- The Egyptian Heart Journal
- Publication Type :
- Academic Journal
- Accession number :
- edsdoj.bd6a84962984e6db6e3ca03383bde66
- Document Type :
- article
- Full Text :
- https://doi.org/10.1186/s43044-022-00291-9